Jan 13 2010
Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) (the "Company" or "Jiangbo"), a pharmaceutical company with its principal operations in China, today announced that one of its factories in China obtained a renewal of its Good Manufacturing Practices Certificate for Pharmaceutical Products ("GMP Certificate") from the State Food and Drug Administration (SFDA) for its tablets and granules.
The new certificate will be valid until November 2014. Jiangbo has another GMP certified factory to produce Traditional Chinese medicines in tablets, granules, pills, mixture, syrup, and concentrated decoction.
According to the National Medicine Administration Law of the People's Republic of China, all pharmaceutical manufacturers are required to pass an examination every five years to renew their GMP Certificates. In November 2009, the examination committee visited the Company and conducted a review of its supply chain management practices, including quality control of raw materials, its manufacturing processes, and the inspection and acceptance of its finished products.
"We are pleased to obtain the renewal of our GMP Certificate, which reinforces Jiangbo's commitment to providing the highest quality pharmaceutical products to patients," said Mr. Wubo Cao, the Company's Chief Executive Officer.
SOURCE Jiangbo Pharmaceuticals, Inc.